Diabetic retinopathy

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 1080-1083

  Bloomgarden, Zachary T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; EXENDIN 4; INSULIN; ORAL ANTIDIABETIC AGENT; PEGAPTANIB; RUBOXISTAURIN; SILDENAFIL; TADALAFIL; TRIAMCINOLONE; VARDENAFIL; VASCULOTROPIN INHIBITOR;

ARTICLE; CLINICAL TRIAL; DIABETIC RETINOPATHY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; HEARING LOSS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; LEUKOSTASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPHTHALMOSCOPY; PANCREATITIS; PREVALENCE; ANIMAL; DISEASE MODEL; GLUCOSE BLOOD LEVEL; MEDICAL EDUCATION; METABOLISM; NOTE; PATHOPHYSIOLOGY; RETINA;

ANIMALS; BLOOD GLUCOSE; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; EDUCATION, MEDICAL, CONTINUING; HUMANS; RETINA;

EID: 48649104240     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-zb05     Document Type: Article

References (10)

1. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV: Diabetes guidelines: easier to preach than to practise? Med J Aust 185: 305-309, 2006
2. Girach A, Manner D, Porta M: Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract 60:1471-1483, 2006
3. Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasega- rane L, Simpson IA, JDRF Diabetic Retinopathy Center Group: Diabetic reti- nopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55:2401-2411, 2006
4. Lieth E, Gardner TW, Barber AJ, An- tonetti DA, Penn State Retina Research Group: Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 28:3-8, 2000
5. Chibber R, Ben-Mahmud BM, Mann GE, Zhang JJ, Kohner EM: Protein kinase C (32- dependent phosphorylation of core 2 Glc- NAc-T promotes leukocyte-endothelial cell adhesion: a mechanism underlying capillary occlusion in diabetic retinopathy. Diabetes 52:1519-1527, 2003
6. Ben-Mahmud BM, Chan WH, Abdulahad RM, Datti A, Orlacchio A, Kohner EM, Chibber R: Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopa- thy. Diabetologia 49:2185-2191, 2006
7. Ben-Mahmud BM, Mann GE, Datti A, Or- lacchio A, Kohner EM, Chibber R: Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy. Diabetes 53:2968-2976, 2004
8. Zhang M, Kho AL, Anilkumar N, Chibber R, Pagano PJ, Shah AM, Cave AC: Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase. Circulation 113: 1235-1243, 2006
9. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thi- eme H, Iwamoto MA, Park JE: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487, 1994
10. Cunningham ET Jr, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD, Macugen Diabetic Retinop- athy Study Group: A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112:1747-1757, 2005